Intervention group | n | ²Ñ±ð²¹²Ô ±â¶Ä‰S¶Ù | MD (95% CI) | ||||
---|---|---|---|---|---|---|---|
Baseline (pre-intervention) | Post-intervention | Within-group change | p-value | Change vs control group | p-value vs control group | ||
6MWT (m) | |||||||
 C°¿±· | 24 | 280.4 ±â¶Ä‰55.2 | 300.8 ±â¶Ä‰58.7 | -20.4 (-30.7, -10.1) | 0.000†| - | - |
 B·¡ | 21 | 286.7 ±â¶Ä‰54.6 | 337.1 ±â¶Ä‰54.1 | -50.5 (-74.6, -26.4) | 0.000†| 21.3 (-21.9,64.5) | 0.545 |
‽ö±õµþ±õ°Õ | 20 | 298.5 ±â¶Ä‰72,4 | 310.0 ±â¶Ä‰60.9 | -11.5 (-43.8, 20.8) | 0.465 | 13.6 (-30.1, 57.4) | 0.834 |
 C·¡ | 22 | 351.8 ±â¶Ä‰55.9 | 403.2 ±â¶Ä‰55.2 | -51.4 (-66.7, -35.9) | 0.000†| 86.9 (44.2, 129.5)†| 0.000†|
Muscle strength (kg) | |||||||
 C°¿±· | 24 | 16.8 ±â¶Ä‰3.4 | 17.7 ±â¶Ä‰3.9 | -0.9 (-1.4, -0.3) | 0.003†| - | - |
 B·¡ | 21 | 16.7 ±â¶Ä‰3.7 | 17.8 ±â¶Ä‰3.9 | -1.0 (-1.6, -0.5) | 0.001†| 0 (-2.8,2.8) | 1.000 |
‽ö±õµþ±õ°Õ | 20 | 15.7 ±â¶Ä‰3.5 | 16.8 ±â¶Ä‰3.7 | -1.1 (-1.9, -0.3) | 0.007†| -1.0 (-3.8,1.8) | 0.766 |
 C·¡ | 22 | 16.4 ±â¶Ä‰3.1 | 17.4 ±â¶Ä‰3.2 | -1.0 (-1.9, 0.1) | 0.064 | -0.3 (-3.1, 2.4) | 0.987 |
Total cholesterol (mg/dL) | |||||||
 C°¿±· | 24 | 208.6 ±â¶Ä‰35.5 | 197.9 ±â¶Ä‰31.7 | 10.7 (0.6, 20.8) | 0.039* | - | - |
 B·¡ | 21 | 199.1 ±â¶Ä‰32.3 | 186.3 ±â¶Ä‰32.3 | 12.8 (5.4, 20.2) | 0.002†| -10.5 (-31.9, 10.9) | 0.547 |
‽ö±õµþ±õ°Õ | 20 | 217.9 ±â¶Ä‰32.6 | 189.7 ±â¶Ä‰23.9 | 28.2 (14.7, 41.7) | 0.021* | 0.5 (-21.2, 22.3) | 1.000 |
 C·¡ | 22 | 193.8 ±â¶Ä‰15.9 | 171.0 ±â¶Ä‰17.6 | 22.8 (16.1, 29.5) | 0.000†| -20.8 (-41.9, 0.4)* | 0.046* |
LDL (mg/dL) | |||||||
 C°¿±· | 24 | 144.7 ±â¶Ä‰31.0 | 137.5 ±â¶Ä‰28.6 | 7.2 (1.2, 13.2) | 0.021* | - | - |
 B·¡ | 21 | 131.1 ±â¶Ä‰26.5 | 117.9 ±â¶Ä‰24,8 | 13.3 (6.4, 20.2) | 0.001†| -16.6 (-34.3, 1.2) | 0.064 |
‽ö±õµþ±õ°Õ | 20 | 146.4 ±â¶Ä‰24.4 | 116.3 ±â¶Ä‰16.5 | 30.1 (19.5, 40.7) | 0.000†| -9.7 (-27.7, 8.3) | 0.466 |
 C·¡ | 22 | 133.5 ±â¶Ä‰15.5 | 108.5 ±â¶Ä‰12.4 | 25.0 (18.5, 31.6) | 0.000†| -20.1 (-37.6, -2.5)* | 0.014* |
HDL (mg/dL) | |||||||
 C°¿±· | 24 | 72.5 ±â¶Ä‰10.8 | 79.3 ±â¶Ä‰9.7 | -6.8 (-9.6, -3.9) | 0.000†| - | - |
 B·¡ | 21 | 69.0 ±â¶Ä‰9.1 | 75.5 ±â¶Ä‰8.7 | -6.5 (-10.2, -2.7) | 0.002†| -3.7 (-10.2, 2.9) | 0.438 |
‽ö±õµþ±õ°Õ | 20 | 71.6 ±â¶Ä‰9.1 | 78.3 ±â¶Ä‰7.2 | -6.8 (-10.2, -3.3) | 0.001†| -0.9 (-7.6, 5.7) | 0.980 |
 C·¡ | 22 | 66.1 ±â¶Ä‰7.5 | 77.1 ±â¶Ä‰7.3 | -10.9 (-13.3, -8.5) | 0.000†| -4.3 (-10.7, 2.2) | 0.286 |
Triglyceride (mg/dL) | |||||||
 C°¿±· | 24 | 217.3 ±â¶Ä‰66.2 | 197.9 ±â¶Ä‰53.5 | 19.5 (9.3, 29.7) | 0.001†| - | - |
 B·¡ | 21 | 180.1 ±â¶Ä‰57.6 | 162.9 ±â¶Ä‰42.9 | 17.1 (5.1, 29.2) | 0.007†| -36.1 (-78.3, 6.1) | 0.104 |
‽ö±õµþ±õ°Õ | 20 | 211.2 ±â¶Ä‰66.4 | 181.9 ±â¶Ä‰56.3 | 29.4 (19.8, 38.9) | 0.000†| -11.1 (-53.8, 31.7) | 0.897 |
 C·¡ | 22 | 178.0 ±â¶Ä‰40.5 | 156.4 ±â¶Ä‰36.6 | 21.5 (12.2, 30.8) | 0.000†| -40.4 (-82.1, 1.3)* | 0.04* |
Ìý | Ìý | ²Ñ±ð²¹²Ô ±â¶Ä‰S¶Ù | ²Ñ±ð²¹²Ô ±â¶Ä‰S¶Ù | Ìý |